AAA
ETNB

Affinity Asset Advisors’s 89bio ETNB Stock Holding History

Affinity Asset Advisors’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-37,300
Closed -$576K – 89
2023
Q3 		$576K Buy
+37,300
New +$626K 0.16% 70
2023
Q2 		– Sell
-36,200
Closed -$551K – 77
2023
Q1 		$551K Buy
+36,200
New +$472K 0.18% 64

Other funds holding ETNB

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Affinity Asset Advisors's ETNB Position: Q2 2025 in Review

Affinity Asset Advisors sold out of 89bio (ETNB) in Q2 2025, closing a stake of 175,000 shares — an estimated $1.27M sold.

Affinity Asset Advisors first reported a position in ETNB in Q1 2023 and held it in 2 quarters. The position peaked at $3.05M in Q1 2023. 184 funds tracked by Wall St. Rank hold ETNB as of Q2 2025.

  • Affinity Asset Advisors reported no remaining 89bio position as of Q2 2025 after selling out during the quarter.
  • Affinity Asset Advisors sold 175,000 89bio shares in Q2 2025, an estimated $1.27M.
  • Affinity Asset Advisors first reported a position in 89bio in Q1 2023 and held it in 2 quarters.
  • Affinity Asset Advisors's 89bio position peaked at $3.05M in Q1 2023.
  • 184 funds tracked by Wall St. Rank held 89bio as of Q2 2025.

Based on Affinity Asset Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.